TNF and craniosynostosis: Treatment of bone marrow derived macrophages (BMDM) with recombinant IL-10 significantly inhibited LPS-induced TNF-α release (Fig. 1F) suggesting that increased IL-10 in response to CSO may be implicated in lowering of LPS-induced TNF-α release.